News
- March 11, 2013 | blog.AIDS.gov
Conversations from CROI 2013: CDC’s Dr. John Ward
Viral hepatitis was discussed at the recent 2013 Conference on Retroviruses and Opportunistic Infections.
Read Article > - March 07, 2013 | Hepatology
Potential consequences of healthcare recommendations: A focus on the USPSTF
The authors argue that the USPSTF’s recommendations have far-reaching consequences for public health, using the recent CDC hepatitis cohort testing recommendations as a study.
Read Article > - March 05, 2013 | Annals of Internal Medicine
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
This article analyzes various observational studies to determine the association between response to hepatitis C therapy and development of hepatocellular carcinoma in certain populations.
Read Article > - March 04, 2013 | Wall Street Journal
Patient Dilemma: Treat Hepatitis C Now or Hold Out?
A growing number of hepatitis C patients are putting off immediate treatment, electing to wait for a newer generation of less toxic drugs to become available.
Read Article > - February 15, 2013 | CDC MMWR
Completeness of Reporting of Chronic Hepatitis B and C Virus Infections — Michigan, 1995–2008
An evaluation of viral hepatitis surveillance in Michigan showed that reporting of chronic HBV and HCV infections was incomplete; however, reporting has improved over time. The findings suggest the need for additional data sources for risk factor information, especially because data in chronic viral hepatitis case reports might not reflect the current risk for secondary transmission.
Read Study > - February 12, 2013 | AIDS.gov Blog
Sounding the Alarm on a Silent Epidemic: Federal HIV/STD Advisory Group Adopts Viral Hepatitis as Priority
The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC), recently decided to expand its mission scope to target viral hepatitis.
Read Article > - February 06, 2013 | Hepatology
The impact of timing and prioritisation on the cost-effectiveness of birth-cohort testing and treatment for hepatitis C virus in the U.S.
The cost-effectiveness of birth cohort testing for hepatitis C infection is examined, yielding a finding that the greatest return on investment is obtained with patients are treated immediately and those with advanced disease are prioritized.
Read Abract > - January 31, 2013 | BBC News
Spread of hepatitis C pinpointed
A study of Greek injection drug users has revealed a pattern for the spread of hepatitis C, demonstrating that early diagnosis is key to preventing epidemics.
Read Article > - January 31, 2013 | USA TODAY
Hepatitis C found years after transfusion
Patient Greg Hays discovered he has hepatitis C during routine diabetes treatment in 2011; however, he has been infected since the 1960s when he had a blood transfusion.
Watch Video > - January 29, 2013 | Sacramento Bee
National Hepatitis C Survey Prompts Call for All Canadian Boomers to Get Tested
The Canadian Liver Foundation recommends that general practitioners immediately recommend a one-time blood test for all adults born between 1945 and 1975.
Read Press Release >